Search icon

Arrivent Biopharma, Inc.

Company Details

Name: Arrivent Biopharma, Inc.
Jurisdiction: Rhode Island
Entity type: Foreign Corporation
Status: Revoked Entity
Date of Organization in Rhode Island: 28 Dec 2023 (a year ago)
Date of Dissolution: 17 Sep 2024 (7 months ago)
Date of Status Change: 17 Sep 2024 (7 months ago)
Identification Number: 001766756
Place of Formation: DELAWARE
Principal Address: 18 CAMPUS BLVD SUITE 100, NEWTOWN SQUARE, PA, 19073, USA
Purpose: BIOPHARMACEUTICAL COMPANY WITH A MISSION TO GLOBALLY DEVELOP TOP BIOPHARMA INNOVATIONS FROM AROUND THE WORLD TO DELIVER IMPORTANT MEDICINES TO PATIENTS. EMPLOYEE RESIDES IN STATE AND WORKS REMOTELY.

Agent

Name Role Address
CORPORATION SERVICE COMPANY Agent 222 JEFFERSON BOULEVARD SUITE 200, WARWICK, RI, 02888, USA

PRESIDENT

Name Role Address
ZHENGBIN YAO PRESIDENT 18 CAMPUS BOULEVARD, STE 100 NEWTOWN SQUARE, PA 19073 USA

TREASURER

Name Role Address
ROBIN LACHAPELLE TREASURER 18 CAMPUS BOULEVARD, STE 100 NEWTOWN SQUARE, PA 19073 USA

SECRETARY

Name Role Address
JAMES KASTENMAYER SECRETARY 18 CAMPUS BOULEVARD, STE 100 NEWTOWN SQUARE, PA 19073 USA

VICE PRESIDENT

Name Role Address
ROBIN LACHAPELLE VICE PRESIDENT 18 CAMPUS BOULEVARD, STE 100 NEWTOWN SQUARE , PA 19073 USA

Filings

Number Name File Date
202459648680 Revocation Certificate For Failure to File the Annual Report for the Year 2024-09-17
202457378020 Revocation Notice For Failure to File An Annual Report 2024-06-25
202343475060 Application for Certificate of Authority 2023-12-28

Date of last update: 29 Oct 2024

Sources: Rhode Island Department of State